A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)

Memorial Sloan Kettering Cancer Center, New York

H. Lee Moffitt Cancer Center & Research Institute, Tampa

University of Michigan, Ann Arbor

University of Colorado Denver, Denver

University of California, Los Angeles (UCLA), Los Angeles

UCSF, San Francisco

Dana-Farber Cancer Institute - Head and Neck Oncology, Boston

National Cancer Center, Goyang-si

Asan Medical Center, Seoul

Seoul National University Hospital, Seoul

Samsung Medical Center, Seoul